Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Worthmann

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Journal of Atherosclerosis and Thrombosis|May 14, 2011
High plasma dimethylarginine levels are associated with adverse clinical outcome after strokeHans Worthmann, Shufen Chen, Jens Martens-Lobenhoffer, et al.
Stroke|February 9, 2013
Association of molecular markers with perihematomal edema and clinical outcome in intracerebral hemorrhageNa Li, Yan Fang Liu, Li Ma, et al.
Clinical Biochemistry|February 21, 2012
Anticoagulants affect matrix metalloproteinase 9 levels in blood samples of stroke patients and healthy controlsMunir Rababah, Hans Worthmann, Milani Deb, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 27, 2011
Growth differentiation factor 15 plasma levels and outcome after ischemic strokeHans Worthmann, Tibor Kempf, Christian Widera, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2012
Circulating endothelial cells as potential diagnostic biomarkers in primary central nervous system vasculitisMilani Deb-Chatterji, Stefan Gerdes, Meike Heeren, et al.
Journal of Thrombosis and Thrombolysis|September 5, 2019
ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysisAnne-Sophie Putzer, Hans Worthmann, Gerrit M Grosse, et al.
Thrombosis and Haemostasis|April 5, 2018
ADAMTS-13 Activity Predicts Outcome in Acute Ischaemic Stroke Patients Undergoing Endovascular TreatmentRamona Schuppner, Meike Dirks, Gerrit M Grosse, et al.
Scientific Reports|October 30, 2023
Interplay between driveline infection, vessel wall inflammation, cerebrovascular events and mortality in patients with left ventricular assist deviceJuliane Hupe, Hans Worthmann, Kim K Ravenberg, et al.
Brain, Behavior, and Immunity|May 19, 2021
Autoantibodies against the NMDAR subunit NR1 are associated with neuropsychiatric outcome after ischemic strokeNadine R Deutsch, Hans Worthmann, Agnes A Steixner-Kumar, et al.
Journal of Neuroinflammation|May 2, 2023
Correction: Association of dimethylarginines and mediators of inflammation after acute ischemic strokeShufen Chen, Jens Martens-Lobenhoffer, Karin Weissenborn, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Journal of Atherosclerosis and Thrombosis|May 14, 2011
High plasma dimethylarginine levels are associated with adverse clinical outcome after strokeHans Worthmann, Shufen Chen, Jens Martens-Lobenhoffer, et al.
Stroke|February 9, 2013
Association of molecular markers with perihematomal edema and clinical outcome in intracerebral hemorrhageNa Li, Yan Fang Liu, Li Ma, et al.
Clinical Biochemistry|February 21, 2012
Anticoagulants affect matrix metalloproteinase 9 levels in blood samples of stroke patients and healthy controlsMunir Rababah, Hans Worthmann, Milani Deb, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 27, 2011
Growth differentiation factor 15 plasma levels and outcome after ischemic strokeHans Worthmann, Tibor Kempf, Christian Widera, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2012
Circulating endothelial cells as potential diagnostic biomarkers in primary central nervous system vasculitisMilani Deb-Chatterji, Stefan Gerdes, Meike Heeren, et al.
Journal of Thrombosis and Thrombolysis|September 5, 2019
ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysisAnne-Sophie Putzer, Hans Worthmann, Gerrit M Grosse, et al.
Thrombosis and Haemostasis|April 5, 2018
ADAMTS-13 Activity Predicts Outcome in Acute Ischaemic Stroke Patients Undergoing Endovascular TreatmentRamona Schuppner, Meike Dirks, Gerrit M Grosse, et al.
Scientific Reports|October 30, 2023
Interplay between driveline infection, vessel wall inflammation, cerebrovascular events and mortality in patients with left ventricular assist deviceJuliane Hupe, Hans Worthmann, Kim K Ravenberg, et al.
Brain, Behavior, and Immunity|May 19, 2021
Autoantibodies against the NMDAR subunit NR1 are associated with neuropsychiatric outcome after ischemic strokeNadine R Deutsch, Hans Worthmann, Agnes A Steixner-Kumar, et al.
Journal of Neuroinflammation|May 2, 2023
Correction: Association of dimethylarginines and mediators of inflammation after acute ischemic strokeShufen Chen, Jens Martens-Lobenhoffer, Karin Weissenborn, et al.
Pageof 8